Redhill Biopharma Ltd (NASDAQ:RDHL)

17.55
Delayed Data
As of 3:59pm ET
 +0.03 / +0.17%
Today’s Change
6.89
Today|||52-Week Range
22.22
+31.66%
Year-to-Date

Today’s Trading

Previous close17.52
Today’s open17.73
Day’s range17.55 - 17.88
Volume23,742
Average volume (3 months)70,581
Market cap$174.5M
Dividend yield--
Data as of 3:59pm ET, 07/06/2015

Growth & Valuation

Earnings growth (last year)+30.60%
Earnings growth (this year)-12.88%
Earnings growth (next 5 years)--
Revenue growth (last year)+57,366.26%
P/E ratio--
Price/Sales16.81
Price/Book6.11

Competitors

 Today’s
change
Today’s
% change
RPRXRepros Therapeutics ...+0.03+0.42%
BITIBiotie Therapies Oyj+1.05+5.71%
CATBCatabasis Pharmaceut...+1.24+10.00%
FBIOFortress Biotech Inc-0.05-1.39%
Data as of 4:00pm ET, 07/06/2015

Financials

Next reporting dateJuly 22, 2015
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$6.9M
Annual profit (last year)-$10.6M
Net profit margin-152.71%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Director, Deputy CEO-Finance &
Operations
Ori Shilo
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers